Details for 2012802093
Up to date per 01.04.2026
Actions
Details for 2012802093
Deleted
European Patent
30.04.2014 A
20.06.2018 B1
21.06.2011
US
201161499620 P
25.04.2012
US
201261638288 P
C12N 15/113 20100101AFI20180509BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
No representatives present
Inventor
BETTENCOURT, Brian300 Third Street 3rd Floor Cambridge, MA 02142US
QUERBES, William300 Third Street 3rd Floor Cambridge, MA 02142US
FITZGERALD, Kevin300 Third Street 3rd Floor Cambridge, MA 02142US
FRANK-KAMENETSKY, Maria300 Third Street 3rd Floor Cambridge, MA 02142US
MILSTEIN, Stuart300 Third Street 3rd Floor Cambridge, MA 02142US
SHULGA-MORSKAYA, Svetlana300 Third Street 3rd Floor Cambridge, MA 02142US